Limited long-term data: most evidence is from animal models, with no long-term human study of NNMT inhibition and oncological endpoints
Retrieved from Van Cauwenberghe, J., De Block, C.E., Vanderschueren, D., & Antonio, L
After week 24, the discontinuation rate due to side effects dropped to just 4.2%
Semaglutides Potential in Specific Anemia Cases While semaglutide is not a direct treatment for anemia, it could be helpful in specific cases where anemia is linked to chronic inflammation, obesity, or poorly controlled diabetes
This study explores a new therapeutic strategy for patients with inadequate response to current treatments." With RA affecting 18M+ people worldwide, and many patients not achieving remission despite modern therapies, ELV001 could reshape the treatment paradigm